We are live on ! Find out more
RNVAZ

Rennova Health, Inc. Warrant
RNVAZ

Delisted

RNVAZ was delisted on the 24th of October, 2017.

Back to rankings

5 hedge funds and large institutions have $128K invested in Rennova Health, Inc. Warrant in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding

Funds holding: 5 → 5 (0)

10% less capital invested

Capital invested by funds: $143K → $128K (-$15K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$8.71K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.24K
3
VKH
Virtu KCG Holdings
New York
+$611

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$251
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$105K +$8.71K +323,809 +7%
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$11K – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$11K +$2.24K +83,132 +19%
VKH
4
Virtu KCG Holdings
New York
$1K +$611 +22,707 +50%
UBS Group
5
UBS Group
Switzerland
– -$251 -9,324 -31%

RNVAZ Hedge Fund Activity: Q1 2017 in Review

5 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. Warrant (RNVAZ) for Q1 2017, worth a combined $128K — down 10% from $143K a quarter earlier.

Fund positioning in RNVAZ was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, adding an estimated $8.71K. The largest seller was UBS Group, cutting an estimated $251.

  • 5 institutional investors held Rennova Health, Inc. Warrant (RNVAZ) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $128K of Rennova Health, Inc. Warrant stock for Q1 2017, down 10% quarter-over-quarter.
  • 0 funds opened new Rennova Health, Inc. Warrant positions in Q1 2017 and 0 closed out.
  • The largest Rennova Health, Inc. Warrant buyer in Q1 2017 was Sabby Management, an estimated $8.71K added.
  • The largest Rennova Health, Inc. Warrant seller in Q1 2017 was UBS Group, an estimated $251 sold.

Based on aggregated 13F filings for Q1 2017.